Li Dean Y 4
4 · Merck & Co., Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Li Dean Y
Executive VP & President, MRL
Transactions
- Award
Stock Option (Right to Buy)
2024-04-30+65,625→ 65,625 totalExercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (65,625 underlying)
Holdings
- 46,402.098
Common Stock
Footnotes (2)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.